A molecular analysis was carried out in 63 sequentially diagnosed chil
dhood acute lymphoblastic leukemia (ALL) patients and 1011 controls to
investigate the homozygosity rate for HLA-DR53. HLA-DR53 is associate
d with acute myeloblastic leukemia at the protein level, and our previ
ous study has shown its association with early-onset chronic myeloid l
eukemia only in homozygous form at the DNA level. In the present study
, the homozygosity rates for DR53 were 17.5 and 13.6% in patients and
controls, respectively. Ten of the 11 homozygous patients were boys. I
n the common ALL group (n = 40), all seven DR53 homozygous patients we
re boys, and among 19 girls this genotype was not observed (P = 0.006)
. For males, homozygosity for DR53 revealed a relative risk (RR) of 3.
29 (P = 0.008) for common ALL. Five of the 11 relapsed patients were h
omozygous for DR53. Heterozygous frequencies for HLA-DR53 were not dif
ferent between patients and controls. Homozygosity for DR53 was associ
ated with a very high relapse rate (45.5 vs 7.7%, P = 0.002, RR = 9.1)
. These results extended our findings in chronic myeloid leukemia acid
showed the recessive nature and the male predominance of the interact
ive HLA influence on the development of childhood leukemia. Molecular
mimicry of an HLA-DR53 epitope by oncogenic (retro)viruses or putative
susceptibility genes in linkage dis-equilibrium with HLA-DR53 may be
responsible for this association.